ORIGINAL RESEARCH article
Front. Stroke
Sec. Population Health and Risk Factors of Stroke
Volume 4 - 2025 | doi: 10.3389/fstro.2025.1598711
This article is part of the Research TopicBridging The Gap of Unmet Need in Stroke Care in Developing CountriesView all 17 articles
A Comparative Analysis of TOAST and ASCOD Criteria in Etiologic Sub-typing of Acute Ischemic Stroke at a Tertiary Hospital in Tanzania
Provisionally accepted- 1Aga Khan University, Dar es Salaam, Tanzania
- 2Aga Khan Hospital Dar es Salaam, Dar es Salaam, Tanzania
- 3Kilimanjaro Christian Medical Centre, Moshi, Arusha, Tanzania
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Etiologic subtyping of ischemic stroke is crucial for determining its treatment, prognosis, and prevention. However, data on the widely utilized TOAST and ASCOD criteria remain scarce in the East African region. Aims: The study aimed to compare the performance of TOAST and ASCOD systems in subtyping ischemic stroke among stroke patients at a tertiary hospital in Tanzania. Methods: This was an institutional cross-sectional study. All adults (≥18 years) admitted with a diagnosis of stroke over a six-year period were selected from the registry, and their clinical details reviewed retrospectively. One hundred and thirty (130) patients with first-or second-time acute stroke (as defined by the World Health Organization) were included. Acute stroke was confirmed as ischemic by magnetic resonance imaging (MRI). For each index stroke, TOAST and ASCOD criteria were applied. The discordance and level of agreement between the approaches were assessed using McNemar's test χ² (P-value) and Cohen's Kappa coefficient (κ), respectively. The value of κ was interpreted as: moderate (0.41 to 0.6), good (0.61 to 0.8), very good (0.81 to 0.9), and excellent (0.91 to 1.0). Statistical significance was set at P < 0.05. Results: There was no significant discordance between TOAST and grade 1 level of evidence of ASCOD (ASCOD1) in assigning stroke to all subtypes, except for Undetermined etiology χ² (P = 0.023). Agreement between these systems was good to very good (κ = 0.601 to 0.843, P < 0.01) across the subtypes. TOAST and ASCOD1 failed to determine a definitive etiology in 34.6% and 48.5% strokes, respectively. On comparing TOAST versus combined grade of evidence 1 and 2 of ASCOD (ASCOD1,2), there was a discordance in allocation of strokes to the Cardioembolic subtype χ² (P < 0.001), and agreement was moderate (κ = 0.471, P=0.001). However, the agreement across other identified subtypes was good to very good (κ = 0.601 to 0.875, P ≤ 0.001). Conclusion: There was a good to very good agreement between TOAST and ASCOD1 in etiologic subtyping of ischemic stroke. Further research is warranted to evaluate their consistency across diverse local settings and to explore factors influencing their performance.
Keywords: ischemic stroke, ischemic stroke subtypes, The Trial of Org 10172 in Acute Stroke Treatment (TOAST), Atherosclerosis, small vessel disease, cardiac pathology, Other cause, and Dissection (ASCOD)
Received: 23 Mar 2025; Accepted: 24 Sep 2025.
Copyright: © 2025 Mohammed, Mabelele, Mbithe, Jusabani and Adebayo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Mukasa Mohammed, drmukasamohammed@gmail.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.